BioSpace News Archive

Preliminary results show that the safety profile of cabiralizumab plus Opdivo was generally consistent with that of Opdivo monotherapy, and that the combination results in dose-related decreases in circulating monocytes.

The Mexican government chose the LIGHTLas 810 laser for its bells and whistles.

Medidata announced the launch of its Strategic Monitoring suite, which meets ICH E6 guidelines and exceeds requirements by empowering clinical research teams to collaborate and manage all cross-functional, risk management and centralized data monitoring activities through seamless, end-to-end workflows.

In the petition, the Company asserts, among other things, breach of contract against Schneider Finance, LLC for its failure to close its purchase of 1,000,000 shares of Series E Preferred Stock of the Company for gross proceeds of $20,000,000 as required by the securities purchase agreement signed May 3, 2017.

The updates will be showcased during the American Academy of Ophthalmology (AAO) 2017 Meeting in New Orleans, November 11-14.

AAO attendees can see Optovue’s suite of advanced eye care products including the new AngioVue Essential OCTA capability in booth #3126.

Lombard Medical begins trading today on OTCQX under the symbol “EVARF.”

The goal is to establish bacteriophages as an approved drug for treating bacterial infections.

The company has expanded its sample preparation and bioprocessing laboratory service.

During this call Lishan Aklog, M.D., the Company’s Chairman and Chief Executive Officer, will provide a business update including an overview of the Company’s near-term milestones and growth strategy.